HEMATOLOGIC MALIGNANCIES
Clinical trials for HEMATOLOGIC MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC MALIGNANCIES trials appear
Sign up with your email to follow new studies for HEMATOLOGIC MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial hopes to tame advanced cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called INCA036873 in about 280 adults with advanced solid tumors or certain blood cancers that have not responded to prior treatments. The main goals are to check the drug's safety and find the right dose. This study is not expected to cure…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 26, 2026 10:07 UTC
-
New trial aims to shield blood cancer patients from Post-CAR-T infections
Disease control Recruiting nowThis phase 2 trial tests whether giving immunoglobulin (antibody) replacement therapy can prevent serious bacterial infections in people receiving CAR-T cell therapy for blood cancers. CAR-T therapy often depletes the body's own antibodies, raising infection risk. The study will …
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 26, 2026 10:06 UTC
-
Blood cancer patients get continued access to promising drug in extension trial
Disease control Recruiting nowThis study offers ongoing tafasitamab treatment to people with blood cancers who are already benefiting from it in a previous study. It aims to keep their disease under control while monitoring for side effects. About 25 adults who are tolerating the drug well and have stable or …
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New pill shows promise against tough blood cancers
Disease control Recruiting nowThis study tests an experimental oral drug, MK-1026 (nemtabrutinib), in people with certain blood cancers like chronic lymphocytic leukemia, lymphoma, and Waldenstrom's macroglobulinemia. The goal is to see if the drug can shrink tumors and control the disease. About 490 adults w…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Smartphone app aims to ease CAR-T therapy side effects for cancer patients
Disease control Recruiting nowThis study tests whether a digital health app with remote monitoring can help 190 patients and their caregivers better manage symptoms and distress during and after CAR-T therapy for blood cancers. Patients use the app to report symptoms, and caregivers track their own stress lev…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE3 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New hope for leukemia patients: drug duo aims to control disease without lifelong meds?
Disease control Recruiting nowThis study tests a combination of two drugs (ICP-248 and orelabrutinib) in people with untreated chronic lymphocytic leukemia or small lymphocytic lymphoma. The goal is to see if the combo is safe and tolerable. About 226 adults aged 18 to 80 will take part. The approach aims to …
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE2, PHASE3 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New hope for advanced cancers: experimental drug IM-1021 enters human testing
Disease control Recruiting nowThis early-stage study tests a new drug called IM-1021 in people with advanced solid tumors or certain blood cancers (lymphomas) that have not responded to other treatments. The main goals are to check the drug's safety and find the best dose. About 117 adults will take part in t…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE1 • Sponsor: Immunome, Inc. • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
Heart risk under the microscope: new study tracks cancer drug side effects
Knowledge-focused Recruiting nowThis study watches how BTK inhibitors, a type of leukemia treatment, affect the heart's rhythm. About 135 adults with certain blood cancers who are taking or about to start these drugs will have heart tests like EKGs, stress tests, and heart imaging. The goal is to spot dangerous…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 26, 2026 10:08 UTC